Logo image of CRUS

CIRRUS LOGIC INC (CRUS) Stock Fundamental Analysis

NASDAQ:CRUS - Nasdaq - US1727551004 - Common Stock - Currency: USD

95.54  -0.5 (-0.52%)

After market: 95.54 0 (0%)

Fundamental Rating

7

Taking everything into account, CRUS scores 7 out of 10 in our fundamental rating. CRUS was compared to 109 industry peers in the Semiconductors & Semiconductor Equipment industry. CRUS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CRUS may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, CRUS could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CRUS had positive earnings in the past year.
In the past year CRUS had a positive cash flow from operations.
CRUS had positive earnings in each of the past 5 years.
Each year in the past 5 years CRUS had a positive operating cash flow.
CRUS Yearly Net Income VS EBIT VS OCF VS FCFCRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

CRUS's Return On Assets of 12.91% is amongst the best of the industry. CRUS outperforms 83.49% of its industry peers.
CRUS has a better Return On Equity (15.54%) than 77.06% of its industry peers.
With an excellent Return On Invested Capital value of 12.68%, CRUS belongs to the best of the industry, outperforming 83.49% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRUS is above the industry average of 11.29%.
Industry RankSector Rank
ROA 12.91%
ROE 15.54%
ROIC 12.68%
ROA(3y)12.08%
ROA(5y)11.62%
ROE(3y)15.39%
ROE(5y)14.96%
ROIC(3y)13.35%
ROIC(5y)12.11%
CRUS Yearly ROA, ROE, ROICCRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 16.55%, CRUS is in the better half of the industry, outperforming 74.31% of the companies in the same industry.
CRUS's Profit Margin has improved in the last couple of years.
The Operating Margin of CRUS (20.44%) is better than 77.98% of its industry peers.
In the last couple of years the Operating Margin of CRUS has grown nicely.
CRUS has a Gross Margin of 52.18%. This is in the better half of the industry: CRUS outperforms 69.72% of its industry peers.
CRUS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.44%
PM (TTM) 16.55%
GM 52.18%
OM growth 3Y3.62%
OM growth 5Y19.01%
PM growth 3Y-1.11%
PM growth 5Y15.12%
GM growth 3Y-0.29%
GM growth 5Y0.32%
CRUS Yearly Profit, Operating, Gross MarginsCRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRUS is creating some value.
CRUS has less shares outstanding than it did 1 year ago.
CRUS has less shares outstanding than it did 5 years ago.
CRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRUS Yearly Shares OutstandingCRUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRUS Yearly Total Debt VS Total AssetsCRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CRUS has an Altman-Z score of 9.55. This indicates that CRUS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.55, CRUS belongs to the best of the industry, outperforming 84.40% of the companies in the same industry.
CRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.55
ROIC/WACC1.35
WACC9.36%
CRUS Yearly LT Debt VS Equity VS FCFCRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CRUS has a Current Ratio of 5.93. This indicates that CRUS is financially healthy and has no problem in meeting its short term obligations.
CRUS has a Current ratio of 5.93. This is amongst the best in the industry. CRUS outperforms 82.57% of its industry peers.
A Quick Ratio of 4.62 indicates that CRUS has no problem at all paying its short term obligations.
CRUS's Quick ratio of 4.62 is fine compared to the rest of the industry. CRUS outperforms 78.90% of its industry peers.
Industry RankSector Rank
Current Ratio 5.93
Quick Ratio 4.62
CRUS Yearly Current Assets VS Current LiabilitesCRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CRUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.38%, which is quite good.
The Earnings Per Share has been growing by 20.11% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 2.99% in the past year.
CRUS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.58% yearly.
EPS 1Y (TTM)13.38%
EPS 3Y12.95%
EPS 5Y20.11%
EPS Q2Q%-13.15%
Revenue 1Y (TTM)2.99%
Revenue growth 3Y9.32%
Revenue growth 5Y8.58%
Sales Q2Q%-10.22%

3.2 Future

Based on estimates for the next years, CRUS will show a small growth in Earnings Per Share. The EPS will grow by 5.91% on average per year.
The Revenue is expected to grow by 5.11% on average over the next years.
EPS Next Y8.93%
EPS Next 2Y2.95%
EPS Next 3Y5.91%
EPS Next 5YN/A
Revenue Next Year6.84%
Revenue Next 2Y3.56%
Revenue Next 3Y5.11%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRUS Yearly Revenue VS EstimatesCRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CRUS Yearly EPS VS EstimatesCRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.42, the valuation of CRUS can be described as correct.
CRUS's Price/Earnings ratio is rather cheap when compared to the industry. CRUS is cheaper than 84.40% of the companies in the same industry.
CRUS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.85.
A Price/Forward Earnings ratio of 13.66 indicates a correct valuation of CRUS.
CRUS's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRUS is cheaper than 82.57% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CRUS to the average of the S&P500 Index (20.77), we can say CRUS is valued slightly cheaper.
Industry RankSector Rank
PE 13.42
Fwd PE 13.66
CRUS Price Earnings VS Forward Price EarningsCRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRUS is valued a bit cheaper than the industry average as 79.82% of the companies are valued more expensively.
97.25% of the companies in the same industry are more expensive than CRUS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.1
EV/EBITDA 10.55
CRUS Per share dataCRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CRUS may justify a higher PE ratio.
PEG (NY)1.5
PEG (5Y)0.67
EPS Next 2Y2.95%
EPS Next 3Y5.91%

0

5. Dividend

5.1 Amount

CRUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CIRRUS LOGIC INC

NASDAQ:CRUS (5/1/2025, 8:53:45 PM)

After market: 95.54 0 (0%)

95.54

-0.5 (-0.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners96.13%
Inst Owner Change0.41%
Ins Owners0.43%
Ins Owner Change8.12%
Market Cap5.08B
Analysts78.57
Price Target123.03 (28.77%)
Short Float %2.85%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.57%
Min EPS beat(2)9.26%
Max EPS beat(2)15.88%
EPS beat(4)4
Avg EPS beat(4)48.33%
Min EPS beat(4)9.26%
Max EPS beat(4)89.62%
EPS beat(8)8
Avg EPS beat(8)39.59%
EPS beat(12)12
Avg EPS beat(12)37.02%
EPS beat(16)15
Avg EPS beat(16)30.95%
Revenue beat(2)2
Avg Revenue beat(2)4.42%
Min Revenue beat(2)2.07%
Max Revenue beat(2)6.77%
Revenue beat(4)4
Avg Revenue beat(4)9.76%
Min Revenue beat(4)2.07%
Max Revenue beat(4)15.17%
Revenue beat(8)7
Avg Revenue beat(8)7.77%
Revenue beat(12)11
Avg Revenue beat(12)8.55%
Revenue beat(16)14
Avg Revenue beat(16)6.75%
PT rev (1m)-7.81%
PT rev (3m)-7.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20.44%
EPS NY rev (1m)0%
EPS NY rev (3m)9.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.68%
Valuation
Industry RankSector Rank
PE 13.42
Fwd PE 13.66
P/S 2.75
P/FCF 11.1
P/OCF 10.48
P/B 2.59
P/tB 3.38
EV/EBITDA 10.55
EPS(TTM)7.12
EY7.45%
EPS(NY)6.99
Fwd EY7.32%
FCF(TTM)8.6
FCFY9.01%
OCF(TTM)9.12
OCFY9.54%
SpS34.69
BVpS36.94
TBVpS28.28
PEG (NY)1.5
PEG (5Y)0.67
Profitability
Industry RankSector Rank
ROA 12.91%
ROE 15.54%
ROCE 17.51%
ROIC 12.68%
ROICexc 17.18%
ROICexgc 24.18%
OM 20.44%
PM (TTM) 16.55%
GM 52.18%
FCFM 24.8%
ROA(3y)12.08%
ROA(5y)11.62%
ROE(3y)15.39%
ROE(5y)14.96%
ROIC(3y)13.35%
ROIC(5y)12.11%
ROICexc(3y)17.57%
ROICexc(5y)16.14%
ROICexgc(3y)27.26%
ROICexgc(5y)24.15%
ROCE(3y)18.43%
ROCE(5y)16.72%
ROICexcg growth 3Y3.78%
ROICexcg growth 5Y15.34%
ROICexc growth 3Y2.32%
ROICexc growth 5Y17.66%
OM growth 3Y3.62%
OM growth 5Y19.01%
PM growth 3Y-1.11%
PM growth 5Y15.12%
GM growth 3Y-0.29%
GM growth 5Y0.32%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 54.74%
Cap/Sales 1.48%
Interest Coverage 250
Cash Conversion 113.57%
Profit Quality 149.87%
Current Ratio 5.93
Quick Ratio 4.62
Altman-Z 9.55
F-Score7
WACC9.36%
ROIC/WACC1.35
Cap/Depr(3y)59.75%
Cap/Depr(5y)50.89%
Cap/Sales(3y)1.92%
Cap/Sales(5y)1.79%
Profit Quality(3y)113.36%
Profit Quality(5y)132.62%
High Growth Momentum
Growth
EPS 1Y (TTM)13.38%
EPS 3Y12.95%
EPS 5Y20.11%
EPS Q2Q%-13.15%
EPS Next Y8.93%
EPS Next 2Y2.95%
EPS Next 3Y5.91%
EPS Next 5YN/A
Revenue 1Y (TTM)2.99%
Revenue growth 3Y9.32%
Revenue growth 5Y8.58%
Sales Q2Q%-10.22%
Revenue Next Year6.84%
Revenue Next 2Y3.56%
Revenue Next 3Y5.11%
Revenue Next 5YN/A
EBIT growth 1Y15.37%
EBIT growth 3Y13.28%
EBIT growth 5Y29.21%
EBIT Next Year19.05%
EBIT Next 3Y15.14%
EBIT Next 5YN/A
FCF growth 1Y-11.4%
FCF growth 3Y5.29%
FCF growth 5Y17.53%
OCF growth 1Y-11.84%
OCF growth 3Y6.52%
OCF growth 5Y15.33%